https://it.marketscreener.com/quotazioni/azione/TERNS-PHARMACEUTICALS-INC-118621672/attualita/Terns-Pharmaceuticals-Inc-evidenzia-nuovi-dati-preclinici-per-il-programma-TERN-601-nell-obesita-44216646/?utm_source=telegram&utm_medium=social&utm_campaign=share